La Jolla Pharmaceutical Company Made Big Gain
Tue, Feb 04, 2020 at 05:30 PM
La Jolla Pharmaceutical Company (LJPC:NASDAQ) rocketted at $8.39, a gain of 21.8%. On Mon 03 Feb 20, LJPC:NASDAQ hit a New 2-Week Intraday Low of $6.77. The stock got featured on our News Catalysts scanner on Sat 18 Jan 20 at 09:39 PM in the 'INSIDER' category. From Mon 13 Jan 20, the stock recorded 35.71% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About La Jolla Pharmaceutical Company (LJPC:NASDAQ)
La Jolla Pharmaceutical Co is an American biopharmaceutical company. It is focused on the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases.
Top 10 Gainers:
- ContraFect Corporation (CFRX:NASDAQ), 968.49%
- Myomo, Inc. (MYO:NYSEMKT), 114.71%
- iBio, Inc. (IBIO:NYSEMKT), 61.69%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 36.84%
- Puma Biotechnology, Inc. (PBYI:NASDAQ), 31.59%
- Digital Ally, Inc. (DGLY:NASDAQ), 28.13%
- Allot Ltd. (ALLT:NASDAQ), 26.78%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 21.77%
- Aduro BioTech, Inc. (ADRO:NASDAQ), 20.43%
- Blink Charging Co. (BLNK:NASDAQ), 20.29%